When U.S. medicine declared pain “the fifth vital sign” in the 1990s, it was a call to take patients seriously. At its core was the belief that tracking pain as carefully as the other four vital signs—heart rate, blood pressure, temperature, and breathing rate—would improve care. But when opioid promoters co-opted this new standard with unethical […]
Author Archives: Seth Lederman
Seth Lederman is co-founder, CEO and chairman of Tonix Pharmaceuticals Holding Corp., a biotech company dedicated to developing novel medicines for central nervous system disorders. Its new first-line fibromyalgia treatment, TonmyaTM, is the first FDA-approved therapy for the chronic pain disorder in over 15 years. He wrote this for InsideSources.com